Air France-KLM - Financial statements and notes to the financial statements as of June 30, 2024
July 25, 2024 02:15 ET
|
AIR FRANCE - KLM
Air France-KLM - Financial statements and notes to the financial statements as of June 30, 2024
Attachment
2024.06 - Air France-KLM - Financial statements and notes to the...
Air France-KLM - Etats financiers et notes annexes au 30 juin 2024
July 25, 2024 02:15 ET
|
AIR FRANCE - KLM
Air France-KLM - Etats financiers et notes annexes au 30 juin 2024
Pièce jointe
2024.06 - Air France-KLM - Etats financiers et notes annexes au 30 juin 2024
...
Air France-KLM Half Year Results
July 25, 2024 02:15 ET
|
AIR FRANCE - KLM
xx SECOND QUARTER 2024 July 25, 2024 Operating result of €513 million with operating margin at 6.5% impacted by unit cost and higher fuel price Group capacity increased by 4.1% compared to last year...
Resultats semestriels d'Air France-KLM
July 25, 2024 02:15 ET
|
AIR FRANCE - KLM
xx DEUXIEME TRIMESTRE 2024 25 juillet 2024 Résultat d'exploitation de 513 millions d’euros, marge opérationnelle à 6.5% impactés par le coût unitaire et un prix du carburant plus élevé Capacité du...
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
July 25, 2024 01:00 ET
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Launch across...
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised
July 25, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Group sales were up by 5%1 at constant exchange rates (CER) (stable in CHF) in the first half, driven by the high demand for both our medicines and diagnostics; excluding COVID-19-related products,...
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Halbjahr 2024 um 5% (CER); starkes Wachstum im zweiten Quartal – Gewinnprognose für das Gesamtjahr erhöht
July 25, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Konzernverkäufe stiegen im ersten Halbjahr um 5%1 zu konstanten Wechselkursen (CER; stabil in CHF) dank starker Nachfrage sowohl nach Medikamenten als auch nach Diagnostika; ohne COVID-19-Produkte...
Dassault Systèmes: Second Quarter 2024 Results in Line With Preliminary Announcement - Non-IFRS Diluted EPS up 10% in the First Half
July 25, 2024 00:59 ET
|
Dassault Systemes SE
Press Release VELIZY-VILLACOUBLAY, France — July 25, 2024 Dassault Systèmes: Second Quarter 2024 Results in Line With Preliminary Announcement Non-IFRS Diluted EPS up 10% in the First Half ...
Dassault Systèmes : deuxième trimestre 2024 conforme à l’annonce préliminaire - Hausse de 10% du BNPA non-IFRS au premier semestre
July 25, 2024 00:59 ET
|
Dassault Systemes SE
Communiqué de Presse VELIZY-VILLACOUBLAY, France — 25 juillet 2024 Dassault Systèmes : deuxième trimestre 2024 conforme à l’annonce préliminaire Hausse de 10% du BNPA non-IFRS au premier...
Dassault Systèmes: Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
July 25, 2024 00:58 ET
|
Dassault Systemes SE
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience AI-enhanced solution will help Eisai accelerate data review and reconciliation...